Crossmark

Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study

Published Online: 2016-06-01

Published Print: 2016-12

Authors

Zentner, Isaac

Schlecht, Hans P.

Khensouvann, Lorna

Tamuhla, Neo

Kutzler, Michele

Ivaturi, Vijay

Pasipanodya, Jotam G.

Gumbo, Tawanda

Peloquin, Charles A.

Bisson, Gregory P.

Vinnard, Christopher
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (K23AI102639, R21AI104441)

Bill and Melinda Gates Foundation
License Information

Text and Data Mining valid from 2016-06-01

Version of Record valid from 2016-06-01
More Information

Article History

Received: 13 November 2015

Accepted: 17 May 2016

First Online: 1 June 2016

Document is current